% IMPORTANT: The following is UTF-8 encoded. This means that in the presence
% of non-ASCII characters, it will not work with BibTeX 0.99 or older.
% Instead, you should use an up-to-date BibTeX implementation like “bibtex8” or
% “biber”.
@ARTICLE{Jessen:163975,
author = {Jessen, Frank and Wolfsgruber, Steffen and Kleineindam,
Luca and Spottke, Annika and Altenstein, Slawek and Bartels,
Claudia and Berger, Moritz and Brosseron, Frederic and
Daamen, Marcel and Dichgans, Martin and Dobisch, Laura and
Ewers, Michael and Fenski, Friederike and Fließbach, Klaus
and Freiesleben, Silka Dawn and Glanz, Wenzel and Görß,
Doreen and Gürsel, Selim and Janowitz, Daniel and Kilimann,
Ingo and Kobeleva, Xenia and Lohse, Andrea and Maier,
Franziska and Metzger, Coraline and Munk, Matthias and
Preis, Lukas and Sanzenbacher, Carolin and Spruth, Eike
Jakob and Rauchmann, Boris Stephan and Vukovich, Ruth C. and
Yakupov, Renat and Weyrauch, Anne-Sophie and Ziegler,
Gabriel and Schmid, Matthias and Laske, Christoph and
Perneczky, Robert and Schneider, Anja and Wiltfang, Jens and
Teipel, Stefan and Bürger, Katharina and Priller, Josef and
Peters, Oliver and Ramirez, Alfredo and Boecker, Henning and
Heneka, Michael T and Wagner, Michael and Düzel, Emrah},
title = {{S}ubjective cognitive decline and stage 2 of {A}lzheimer
disease in patients from memory centers.},
journal = {Alzheimer's and dementia},
volume = {19},
number = {2},
issn = {1552-5260},
address = {Hoboken, NJ},
publisher = {Wiley},
reportid = {DZNE-2022-00644},
pages = {487-497},
year = {2023},
note = {(CC BY-NC-ND)},
abstract = {It is uncertain whether subjective cognitive decline (SCD)
in individuals who seek medical help serves the
identification of the initial symptomatic stage 2 of the
Alzheimer's disease (AD) continuum.Cross-sectional and
longitudinal data from the multicenter, memory clinic-based
DELCODE study.The SCD group showed slightly worse cognition
as well as more subtle functional and behavioral symptoms
than the control group (CO). SCD-A+ cases $(39.3\%$ of all
SCD) showed greater hippocampal atrophy, lower cognitive and
functional performance, and more behavioral symptoms than
CO-A+. Amyloid concentration in the CSF had a greater effect
on longitudinal cognitive decline in SCD than in the CO
group.Our data suggests that SCD serves the identification
of stage 2 of the AD continuum and that stage 2,
operationalized as SCD-A+, is associated with subtle, but
extended impact of AD pathology in terms of
neurodegeneration, symptoms and clinical progression.},
keywords = {Humans / Alzheimer Disease: pathology / Amyloid
beta-Peptides / Cross-Sectional Studies / Cognitive
Dysfunction: diagnosis / Cognition / Biomarkers / tau
Proteins / Alzheimer's disease (Other) / amyloid beta 42
(Other) / apolipoprotein E (Other) / cerebrospinal fluid
(Other) / longitudinal (Other) / magnetic resonance imaging
(Other) / mild cognitive impairment (Other) / positron
emission tomography (Other) / subjective cognitive decline
(Other) / tau (Other)},
cin = {AG Jessen / AG Wagner / AG Klockgether / AG Endres /
Biomarker / AG Boecker / Clinical Research (Munich) / AG
Speck / KAP / AG Düzel / AG Teipel / AG Schmid Bonn / Core
ICRU / AG Schneider / AG Priller / Patient Studies Bonn /
Delcode},
ddc = {610},
cid = {I:(DE-2719)1011102 / I:(DE-2719)1011201 /
I:(DE-2719)1011001 / I:(DE-2719)1811005 / I:(DE-2719)1011301
/ I:(DE-2719)1011202 / I:(DE-2719)1111015 /
I:(DE-2719)1340009 / I:(DE-2719)1340013 / I:(DE-2719)5000006
/ I:(DE-2719)1510100 / I:(DE-2719)1013028 /
I:(DE-2719)1240005 / I:(DE-2719)1011305 / I:(DE-2719)5000007
/ I:(DE-2719)1011101 / I:(DE-2719)5000034},
pnm = {353 - Clinical and Health Care Research (POF4-353)},
pid = {G:(DE-HGF)POF4-353},
experiment = {EXP:(DE-2719)DELCODE-20140101},
typ = {PUB:(DE-HGF)16},
pubmed = {pmid:35451563},
doi = {10.1002/alz.12674},
url = {https://pub.dzne.de/record/163975},
}